Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identifying genetically driven clinical phenotypes using linear mixed models.
Mosley JD, Witte JS, Larkin EK, Bastarache L, Shaffer CM, Karnes JH, Stein CM, Phillips E, Hebbring SJ, Brilliant MH, Mayer J, Ye Z, Roden DM, Denny JC. Mosley JD, et al. Among authors: karnes jh. Nat Commun. 2016 Apr 25;7:11433. doi: 10.1038/ncomms11433. Nat Commun. 2016. PMID: 27109359 Free PMC article.
Comparison of HLA allelic imputation programs.
Karnes JH, Shaffer CM, Bastarache L, Gaudieri S, Glazer AM, Steiner HE, Mosley JD, Mallal S, Denny JC, Phillips EJ, Roden DM. Karnes JH, et al. PLoS One. 2017 Feb 16;12(2):e0172444. doi: 10.1371/journal.pone.0172444. eCollection 2017. PLoS One. 2017. PMID: 28207879 Free PMC article.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.
Karnes JH, Rettie AE, Somogyi AA, Huddart R, Fohner AE, Formea CM, Ta Michael Lee M, Llerena A, Whirl-Carrillo M, Klein TE, Phillips EJ, Mintzer S, Gaedigk A, Caudle KE, Callaghan JT. Karnes JH, et al. Clin Pharmacol Ther. 2021 Feb;109(2):302-309. doi: 10.1002/cpt.2008. Epub 2020 Sep 6. Clin Pharmacol Ther. 2021. PMID: 32779747 Free PMC article.
Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions.
Deshpande P, Hertzman RJ, Palubinsky AM, Giles JB, Karnes JH, Gibson A, Phillips EJ. Deshpande P, et al. Among authors: karnes jh. Clin Pharmacol Ther. 2021 Sep;110(3):607-615. doi: 10.1002/cpt.2343. Epub 2021 Jul 17. Clin Pharmacol Ther. 2021. PMID: 34143437 Free PMC article. Review.
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia.
Karnes JH, Rollin J, Giles JB, Martinez KL, Steiner HE, Shaffer CM, Momozawa Y, Inai C, Bombin A, Shi M, Mosley JD, Stanaway I, Selleng K, Thiele T, Mushiroda T, Pouplard C, Heddle NM, Kubo M, Phillips EJ, Warkentin TE, Gruel Y, Greinacher A, Roden DM. Karnes JH, et al. Blood. 2022 Jul 21;140(3):274-284. doi: 10.1182/blood.2021014240. Blood. 2022. PMID: 35377938 Free PMC article.
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia.
Giles JB, Steiner HE, Rollin J, Shaffer CM, Momozawa Y, Mushiroda T, Inai C, Selleng K, Thiele T, Pouplard C, Heddle NM, Kubo M, Miller EC, Martinez KL, Phillips EJ, Warkentin TE, Gruel Y, Greinacher A, Roden DM, Karnes JH. Giles JB, et al. Among authors: karnes jh. Blood Adv. 2022 Jul 26;6(14):4137-4146. doi: 10.1182/bloodadvances.2022007673. Blood Adv. 2022. PMID: 35533259 Free PMC article.
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort study.
Giles JB, Rollin J, Martinez KL, Selleng K, Thiele T, Pouplard C, Sheppard JI, Heddle NM, Phillips EJ, Roden DM, Gruel Y, Warkentin TE, Greinacher A, Karnes JH. Giles JB, et al. Among authors: karnes jh. Thromb Res. 2023 Sep;229:198-208. doi: 10.1016/j.thromres.2023.07.011. Epub 2023 Jul 20. Thromb Res. 2023. PMID: 37541168 Free PMC article.
73 results